[Long-term organ toxicity of oncological therapies].
1/5 보강
Increasing survival rates following cancer diagnoses, combined with demographic aging, have resulted in a growing population of long-term survivors.
APA
Thong MSY, Doege D, et al. (2026). [Long-term organ toxicity of oncological therapies].. Laryngo- rhino- otologie, 105(4), 224-230. https://doi.org/10.1055/a-2724-6429
MLA
Thong MSY, et al.. "[Long-term organ toxicity of oncological therapies].." Laryngo- rhino- otologie, vol. 105, no. 4, 2026, pp. 224-230.
PMID
41926945 ↗
Abstract 한글 요약
Increasing survival rates following cancer diagnoses, combined with demographic aging, have resulted in a growing population of long-term survivors. Many of these individuals face persistent and late-onset effects of oncological treatments. This article examines the most common sequelae associated with traditional treatment approaches, presents emerging evidence on innovative therapies, and explores their impact on patients' quality of life.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.